Treatment of tuberculosis in developing countries.
Elliott
A M
AM
Mwinga
A G
AG
Foster
S D
SD
D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003906:Developing Countries; D004359:Drug Therapy, Combination; D006679:HIV Seropositivity / Q000150:complications*; D015528:HIV Seroprevalence; D006801:Humans; D007223:Infant; D013636:Tanzania; D013828:Thioacetazone / Q000009:adverse effects*; D014376:Tuberculosis / Q000188:drug therapy*; D015024:Zambia
D000995:Antitubercular Agents; D013828:Thioacetazone